Najat Khan

Director, Recursion Pharmaceuticals.

Companies

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Sep 8, 2026Sold 22,408 shares at $3.52 of Recursion Pharmaceuticals⁴
Aug 17, 2026Shares withheld for tax 80,498 shares at $3.16 of Recursion Pharmaceuticals⁵
Jun 5, 2026Sold 23,588 shares at $3.58 of Recursion Pharmaceuticals⁶
May 15, 2026Shares withheld for tax 62,701 shares at $3.04 of Recursion Pharmaceuticals⁷
Mar 9, 2026Sold 28,298 shares at $3.35 of Recursion Pharmaceuticals⁸
Feb 17, 2026Shares withheld for tax 14,280 shares at $3.49 of Recursion Pharmaceuticals⁹
Feb 6, 2026Shares withheld for tax 10,364 shares at $3.98 of Recursion Pharmaceuticals¹⁰
Feb 6, 2026Granted 30,346 shares of Recursion Pharmaceuticals¹⁰
Feb 6, 2026Granted 1,673,546 shares of Recursion Pharmaceuticals¹⁰
Dec 22, 2025Sold 124,403 shares at $4.41 of Recursion Pharmaceuticals¹¹
Nov 17, 2025Shares withheld for tax 17,584 shares at $4.14 of Recursion Pharmaceuticals¹²
Nov 5, 2025Granted 84,925 shares of Recursion Pharmaceuticals¹³
Aug 18, 2025Sold 36,599 shares at $5.52 of Recursion Pharmaceuticals¹⁴
Aug 15, 2025Shares withheld for tax 3,789 shares at $5.64 of Recursion Pharmaceuticals¹⁴
May 15, 2025Shares withheld for tax 3,796 shares at $4.25 of Recursion Pharmaceuticals¹⁵
Feb 3, 2025Shares withheld for tax 2,753 shares at $7.25 of Recursion Pharmaceuticals¹⁶
Feb 3, 2025Granted 8,049 shares of Recursion Pharmaceuticals¹⁶
Feb 3, 2025Granted 210,113 shares of Recursion Pharmaceuticals¹⁶
Aug 1, 2024Granted 496,972 shares of Recursion Pharmaceuticals¹⁷

The numbers on this page point here. Each one links to the record it came from.